Andromachi Scaradavou
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andromachi Scaradavou as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:34 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07566377 · Cord Blood Transplantation in Children and Young Adults With Blood CancerMemorial Sloan Kettering Cancer Center · recruiting · Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph2NCT06430788 · A Study of Emapalumab for Pediatric Aplastic AnemiaMemorial Sloan Kettering Cancer Center · recruiting · Aplastic Anemia, Cytopenia, Hypocellular Marrow · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:34 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- 608 citationsRCR 14.8
- Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.Blood · 1997238 citationsRCR 8.0
- 140 citationsRCR 4.4
- Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.Blood · 2011104 citationsRCR 3.0
- 79 citationsRCR 2.8
- High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.Biol Blood Marrow Transplant · 201541 citationsRCR 1.4
- Umbilical cord blood transplantation and cytomegalovirus: Posttransplantation infection and donor screening.Blood · 200638 citationsRCR 1.0
- Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.Biol Blood Marrow Transplant · 201737 citationsRCR 1.5
- Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.Biol Blood Marrow Transplant · 201533 citationsRCR 1.5
- Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies.Blood Adv · 202528 citationsRCR 5.5